Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face ...

Shares of AbbVie Inc. ABBV slid 3.14% to $174.20 Thursday, on what proved to be an all-around dismal trading session for the ...

With this in mind, let us now have a look at the Long-Term Stock Portfolio: 15 Best Stocks for 15 Years.

Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios.

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

A significant trading signal occurred for AbbVie stock at $164.86, ahead of tariff reversal news. ABBV climbed up to 9.2% ...

Goldman Sachs reaffirmed its "neutral" rating on AbbVie with a target price of $194, indicating mild optimism without fanfare. Six analysts say “hold,” eighteen say “buy,” and three shout “strong buy” ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

The Allegations: Rosen Law Firm is Investigating the Allegations that Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Misled Investors Regarding its Business Operations.

The European Commission (EC) has granted marketing authorization to Rinvoq (upadacitinib; 15mg, once daily), from US pharma ...